市場調查報告書

3D細胞培養市場 - 各技術、應用、終端用戶、地區:市場規模、佔有率、展望、機會分析 (2020-2027年)

3D Cell Culture Market, By Technology, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968758
出版日期 內容資訊 英文 165 Pages
商品交期: 2-3個工作天內
價格
3D細胞培養市場 - 各技術、應用、終端用戶、地區:市場規模、佔有率、展望、機會分析 (2020-2027年) 3D Cell Culture Market, By Technology, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月30日內容資訊: 英文 165 Pages
簡介

研究開發的投資增加及癌症的高盛行率,預計在預測期間內促進市場成長。再加上對再生醫學的關注高漲,也預期帶給對全球3D細胞培養市場參與企業有利的成長機會。

本報告提供全球3D細胞培養市場相關調查,市場概要,影響市場的因素分析,各市場區隔、各地區的市場分析,並提供主要企業簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各技術
    • 市場明細:各應用領域
    • 市場明細:各終端用戶
    • 市場明細:各地區
    • Coherent Opportunity Map (COM)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的焦點
  • 產品銷售
  • PEST分析
  • 技術的進步
  • 法規方案
  • 合併和收購
  • COVID19對市場的影響

第4章 全球3D細胞培養市場:各技術

  • 簡介
  • 細胞外基質或支架
  • 生物反應器
  • 凝膠
  • 無支架平台
  • 微晶片

第5章 全球3D細胞培養市場:各應用領域

  • 簡介
  • 研究
  • 藥物研發
  • 組織工程
  • 臨床應用
  • 幹細胞生物學

第6章 全球3D細胞培養市場:各終端用戶

  • 簡介
  • 研究實驗室&機關
  • 生物醫藥品產業
  • 醫院&診斷中心
  • 其他

第7章 全球3D細胞培養市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 企業簡介
    • Becton, Dickinson and Company
    • Cardinal Health Inc.
    • Lonza Group
    • Thermo Fisher Scientific, Inc.
    • 3D Biotek LLC
    • 3D Biomatrix, Inc.
    • Global Cell Solutions, Inc.
    • InSphero AG
    • Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)
    • Reinnervate Ltd. (a subsidiary of ReproCELL)

第9章 Section

目錄

Title:
3D Cell Culture Market, By Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free platforms, Microchips), By Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, Stem Cell Biology), By End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals and diagnostic centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

  • 3D cell culture refers to the process of growing cells in their native context or in vivo environment. Cells grown in 3D cell culture exhibit similar properties of cells found inside living organisms in terms of cellular characteristics and behavior. High prevalence of cancer along with increasing investment in research and development is expected to propel the market growth during the forecast period. Moreover, increasing focus on regenerative medicines is also expected to offer lucrative growth opportunities for players in the global 3D cell culture market.

Key features of the study:

  • This report provides in-depth analysis of the Global 3D Cell Culture market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global 3D Cell Culture market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Becton, Dickinson and Company, Lonza Group, Thermo Fisher Scientific, Inc., Corning Incorporated, 3D Biotek LLC, 3D Biomatrix, Inc., Global Cell Solutions, Inc., InSphero AG, Sigma-Aldrich Corporation (a subsidiary of Merck KGaA), and Reinnervate Ltd. (a subsidiary of ReproCELL).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global 3D Cell Culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global 3D Cell Culture market

Detailed Segmentation:

  • Global 3D Cell Culture Market, By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
  • Global 3D Cell Culture Market, By Application:
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
  • Global 3D Cell Culture Market, By End User:
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
  • Global 3D Cell Culture Market, By Region:
  • North America
    • By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
    • By Application
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
    • By End User
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
    • By Application
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
    • By End User
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
    • By Application
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
    • By End User
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
    • By Application
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
    • By End User
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
    • By Application
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
    • By End User
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
    • By Application
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
    • By End User
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Becton, Dickinson and Company *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Lonza Group
  • Thermo Fisher Scientific, Inc.
  • Corning Incorporated
  • 3D Biotek LLC
  • 3D Biomatrix, Inc.
  • Global Cell Solutions, Inc.
  • InSphero AG
  • Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)
  • Reinnervate Ltd. (a subsidiary of ReproCELL)
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions
  • COVID19 Impact on the market

4. Global 3D Cell Culture Market, By Technology, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Extracellular Matrices or Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Bioreactors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Scaffold-free platforms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Microchips
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global 3D Cell Culture Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Clinical Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Stem Cell Biology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global 3D Cell Culture Market, By End User, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Research Labs & Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Biopharmaceutical Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Hospitals and diagnostic centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global 3D Cell Culture Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Company Profiles
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cardinal Health Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lonza Group
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • 3D Biotek LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • 3D Biomatrix, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Global Cell Solutions, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • InSphero AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Reinnervate Ltd. (a subsidiary of ReproCELL)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact